[VYNE] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
12-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -281.50%
YoY- 57.46%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 99 6 167 126 178 2,292 4,086 -91.64%
PBT -5,612 -7,748 -9,255 -8,235 -8,694 -12,018 -21,285 -58.91%
Tax 10 13 204 241 -13,364 -448 3,439 -97.96%
NP -5,622 -7,761 -9,459 -8,476 4,670 -11,570 -21,285 -58.86%
Tax Rate - - - - - - - -
Total Cost 5,721 7,767 9,626 8,602 -4,492 13,862 25,371 -62.98%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -5,678.79 -129,350.00 -5,664.07 -6,726.98 2,623.60 -504.80 -520.93 392.36%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -1.72 -2.60 -2.94 -2.63 1.52 -3.89 -7.36 -62.09%
EPS Diluted -1.72 -2.60 -2.94 -2.63 1.52 -3.89 -7.36 -62.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.